Sep 23, 2019, 8:30 AM
Sep 24, 2019, 6:00 PM
Pasadena Convention Center

About CannMed

CannMed features the greatest minds in medical cannabis. With a booming industry anticipated to exceed $500B by 2028, understanding the complex science and its medical benefits for patients in need is how this conference series was born. Since our inaugural event at Harvard Medical School in 2016, we have been passionately driven to further the scientific and cultural dialogue. Medicinal Genomics invites all attendees or sponsors to experience firsthand why CannMed continues to lead the way in cannabis science.

New venue, one location!
Cocktail hour networking parties
Expanded exhibit space
Multiple ticket price options
Expanded speaker times and Q&A
CME credits available (details coming soon)


Raphael Mechoulam
Hebrew University, Jerusalem
Michael Dor
Israel Ministry of Health, Cannabis Unit
Bonni Goldstein
Medical Director and Owner at Canna-Centers
Catherine Jacobson
VP, Regulatory & Medical Affairs at Tilray
Laboratory of Cancer Biology & Cannabinoid Research - Technion
Dustin Sulak
Founder at Healer
View More (8)
Kevin McKernan
CSO at Medicinal Genomics Corporation
Staci Gruber
McLean Hospital Brain Imaging Center Harvard Medical School
Kaitlyn Laverty
PhD Candidate at the University of Toronto | Functional Genomics
Kevin Fisher
CEO/Co-Founder, Molecular Infusions RK Enterprises Ltd
Susan Audino
Board Member for the Center for Research on Environmental Medicine in Maryland
Ethan Russo
Director of Research and Development International Cannabis and Cannabinoids Institute
Martin A Lee
Director, Project CBD
Reem Smoum-Jaouni
Research Scientist, Medicinal and Organic Chemistry


Agilent Technologies
PAX Labs
Humbold Apothecary
Pure Ratios
View More (6)